Search all trials

Find therapies in clinical trials near you – page 24

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Cutaneous lupus erythematosus

Not recruiting

Investigational

Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Investigational

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Bi 1819479

Contact Research Centre

Encephalitis autoimmune

Not recruiting

Registered drug

Study on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)

Registered drug

Austria

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Dilated cardiomyopathy

Not recruiting

Investigational

Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Ab-1002

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on Long-Term Safety and Effectiveness of Treprostinil Palmitil for Patients with Pulmonary Arterial Hypertension

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Treprostinil Palmitil

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Avelumab

Contact Research Centre

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Essential thrombocythaemia

Not recruiting

Registered drug

Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Bomedemstat

Contact Research Centre

Find therapies in clinical trials near you – page 24

418 trials match your criteria

Plasma cell myeloma

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Cutaneous lupus erythematosus

Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

Squamous cell carcinoma of head and neck

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Idiopathic pulmonary fibrosis

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Encephalitis autoimmune

Study on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)

Dilated cardiomyopathy

Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

Pulmonary arterial hypertension

Study on Long-Term Safety and Effectiveness of Treprostinil Palmitil for Patients with Pulmonary Arterial Hypertension

Transitional cell carcinoma

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Prostate cancer

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

Pulmonary arterial hypertension

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Pulmonary arterial hypertension

Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)

Essential thrombocythaemia

Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.